JACKS: joint analysis of CRISPR/Cas9 knockout screens

Felicity Allen(Wellcome Sanger Institute), Leopold Parts(Wellcome Sanger Institute), Kosuke Yusa(Kyoto University), Francesco Iorio(Wellcome Sanger Institute), Mathew J. Garnett(Wellcome Sanger Institute), Fiona M. Behan(Age UK), Anton Khodak(Wellcome Sanger Institute)
Genome Research
January 23, 2019
10.1101/gr.238923.118
Cited by 113

Related Papers

Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
Drug repurposing: progress, challenges and recommendations
|Nature Reviews Drug Discovery|2018|4.6k
Systematic identification of genomic markers of drug sensitivity in cancer cells
|Nature|2012|2.6k
Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients
|Cell|2015|2.4k
A Landscape of Pharmacogenomic Interactions in Cancer
|Cell|2016|2.3k